Literature DB >> 11490122

Hepatic indocyanine green uptake and excretion in a rabbit model of steatosis.

A M Seifalian1, A El-Desoky, B R Davidson.   

Abstract

Transplantation of a fatty liver is associated with a higher incidence of primary non-function of the graft. Indocyanine green (ICG) has been used for assessing hepatic dysfunction but not for quantifying liver steatosis. New Zealand white rabbits were fed a normal diet (group A) or a high-cholesterol (2%) diet for 4, 8, and 12 weeks in groups B, C, and D, respectively. Laparotomy was performed for liver exposure. Hepatic artery, portal vein, and total blood flow, hepatic microcirculation, portal pressure, liver function parameters, and blood cholesterol levels were measured. The hepatic ICG concentration was measured using near-infrared spectroscopy, and its uptake and excretion rates were calculated. The severity of steatosis was assessed from liver biopsy specimens by a semiquantitative grading system. Cholesterol feeding resulted in mild steatosis after 4 weeks and in moderate steatosis after 8 and 12 weeks. Mild steatosis was associated with insignificant changes in haemodynamic parameters, liver function, and ICG handling as compared with controls. Moderate steatosis caused a significant reduction in portal and total hepatic blood flow and microcirculation with a significant increase in hepatic artery flow and portal pressure. These haemodynamic changes were associated with a significant alteration in liver function tests. With moderate steatosis, ICG uptake and excretion were significantly reduced. The ICG uptake rate significantly correlated with total blood flow and microcirculation. The ICG excretion rate significantly correlated with the changes in bilirubin, liver enzymes, and albumin. Direct ICG quantification by near-infrared spectroscopy could be used to assess the severity of hepatic steatosis by reflecting impaired parenchymal perfusion and liver dysfunction. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11490122     DOI: 10.1159/000049706

Source DB:  PubMed          Journal:  Eur Surg Res        ISSN: 0014-312X            Impact factor:   1.745


  7 in total

1.  Nonalcoholic fatty liver disease (NAFLD) in nonobese patients with diabetes: Prevalence and relationships with hemodynamic alterations detected with Doppler sonography().

Authors:  S Gaiani; A Avogaro; G C Bombonato; M Bolognesi; F Amor; S Vigili de Kreutzenberg; G Guarneri; D Sacerdoti
Journal:  J Ultrasound       Date:  2009-01-20

Review 2.  Hepatic steatosis in type 1 diabetes.

Authors:  Simon E Regnell; Åke Lernmark
Journal:  Rev Diabet Stud       Date:  2012-02-10

3.  Pathophysiological analysis of nonalcoholic fatty liver disease by evaluation of fatty liver changes and blood flow using xenon computed tomography: can early-stage nonalcoholic steatohepatitis be distinguished from simple steatosis?

Authors:  Ryuta Shigefuku; Hideaki Takahashi; Minoru Kobayashi; Hiroki Ikeda; Kotaro Matsunaga; Chiaki Okuse; Nobuyuki Matsumoto; Shiro Maeyama; Shigeru Sase; Michihiro Suzuki; Fumio Itoh
Journal:  J Gastroenterol       Date:  2012-05-11       Impact factor: 7.527

4.  Sonographic Evaluation of Liver Hemodynamic Indices in Overweight and Obese Dogs.

Authors:  A F Belotta; C R Teixeira; C R Padovani; S C Rahal; M N Mayer; M J Mamprim
Journal:  J Vet Intern Med       Date:  2017-12-27       Impact factor: 3.333

5.  Normothermic Ex Vivo Liver Platform Using Porcine Slaughterhouse Livers for Disease Modeling.

Authors:  Melanie Krüger; Alicia Ruppelt; Benjamin Kappler; Elke Van Soest; Roos Anne Samsom; Guy C M Grinwis; Niels Geijsen; J Bernd Helms; Marco Stijnen; Linda M Kock; Marco Rasponi; Hans S Kooistra; Bart Spee
Journal:  Bioengineering (Basel)       Date:  2022-09-14

6.  Deficiency of eNOS exacerbates early-stage NAFLD pathogenesis by changing the fat distribution.

Authors:  Yuichi Nozaki; Koji Fujita; Koichiro Wada; Masato Yoneda; Yoshiyasu Shinohara; Kento Imajo; Yuji Ogawa; Takaomi Kessoku; Makoto Nakamuta; Satoru Saito; Naohiko Masaki; Yoji Nagashima; Yasuo Terauchi; Atsushi Nakajima
Journal:  BMC Gastroenterol       Date:  2015-12-17       Impact factor: 3.067

7.  In Vivo Toxicity Study of Engineered Lipid Microbubbles in Rodents.

Authors:  Gaio Paradossi; Letizia Oddo; Barbara Cerroni; Carmit Ben-Harush; Eti Ariel; Francesco Di Meco; Zvi Ram; Rachel Grossman
Journal:  ACS Omega       Date:  2019-03-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.